Bristol-Myers Squibb Company
ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

Abstract:

Provided herein are agonistic antibodies, or antigen binding portions thereof, that bind to human CD40. Such antibodies optionally comprise Fc regions with enhanced specificity for Fc.gamma.RIIb. The invention also provides methods of treatment of cancer or chronic infection by administering the antibodies of the invention to a subject in need thereof.